To evaluate muscle injury using magnetic resonance imaging after an intragluteal injection of Diclofenac sodium 75mg/ 3ml
Phase 4
Not yet recruiting
- Registration Number
- CTRI/2020/03/024099
- Lead Sponsor
- Apollo Hospitals International Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male above 18 years
Exclusion Criteria
contraindications of Diclofenac sodium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to evaluate muscle injury using MRI following a diclofenac 75mg/3ml intragluteal injectionTimepoint: magnetic resonance imaging will be done at 2,12,22,32,47,62,92,122,182,242 min as well 7.5 hr after administration
- Secondary Outcome Measures
Name Time Method to observe any change in the inflammatory biomarkers following a diclofenac 75 mg/ 3ml intragluteal injectionTimepoint: magnetic resonance imaging will be done at 2,12,22,32,47,62,92,122,182,242 min as well 7.5 hr after administration